MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$490,285K
Inventory
$53,487K
Marketable securities
$49,563K
Accounts receivable, net
$39,031K
Prepaid expenses and
other current assets
$20,261K
Other receivables
$17,106K
Total current assets
$669,733K
Property and equipment,
net
$220,591K
Intangible assets, net
$59,910K
Operating lease
right-of-use assets
$58,390K
Goodwill
$4,511K
Other noncurrent
assets
$2,624K
Total assets
$1,015,759K
Total liabilities and
stockholders equity
$1,015,759K
Total stockholders
equity
$814,324K
Total liabilities
$201,435K
Accumulated deficit
-$1,524,061K
Additional paid-in capital
$2,338,269K
Total current
liabilities
$113,598K
Operating lease
liabilities, noncurrent
$70,059K
Deferred revenue,
noncurrent
$10,138K
Other noncurrent
liabilities
$6,418K
Contingent consideration,
noncurrent
$1,222K
Accumulated other
comprehensive income
$114K
Common stock
$2K
Accrued expenses and
other current...
$33,680K
Deferred revenue
$24,342K
Accrued compensation
and related...
$21,506K
Accounts payable
$17,425K
Operating lease
liabilities
$11,330K
Contingent consideration,
current
$5,315K
Back
Back
Balance Sheet
source: myfinsight.com
10x Genomics, Inc. (TXG)
10x Genomics, Inc. (TXG)